{"id":"W4324311114","doi":"10.1182/bloodadvances.2022008345","title":"The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University Health Centre; Jewish General Hospital; University of Ottawa; McGill University","funders":"National Cancer Institute; National Institutes of Health; Emory University; Terry Fox Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; McGill University; Jewish General Hospital; Canadian Institutes of Health Research; Leukemia and Lymphoma Society","keywords":"Carfilzomib; Proteasome; Bortezomib; Multiple myeloma; Pharmacology; Proteasome inhibitor; Cancer research; Biology; Medicine; Cell biology; Immunology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000188225,0.0002764348,0.0005129735,0.0002037795,0.0001489613,0.0003985976,0.0001653362,0.0003138222,0.0009264025],"category_scores_gemma":[0.0001894782,0.0001411932,0.0003228791,0.0001692813,0.0001879106,0.000165988,0.0003039666,0.0007377512,0.0001666852],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003741803,"about_ca_system_score_gemma":0.0002056034,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00084702,"about_ca_topic_score_gemma":0.00155027,"domain_scores_codex":[0.9998087,0.00003094504,0.0000247614,0.000034478,0.00006257453,0.00003852885],"domain_scores_gemma":[0.9999236,0.0000170672,0.00002366866,0.000007940774,0.0000103854,0.00001729872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002037262,0.00006284446,0.0002260081,0.00008618218,0.00001475831,0.00003902109,0.00001861073,0.0002295022,0.9964329,0.0000545387,0.0001358096,0.002496126],"study_design_scores_gemma":[0.00005141606,0.001345249,0.008368704,0.00001589863,0.00005361205,0.0001740787,0.00003625446,0.001433361,0.9839406,0.00005621721,0.004513205,0.00001153743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901812,0.004666664,0.002225074,0.000282655,0.0001152666,0.00006016018,0.0007205792,0.0002039566,0.001544375],"genre_scores_gemma":[0.9953238,0.001849423,0.001139481,0.0001206494,0.00001471116,0.00004062648,0.0005457277,0.00001729484,0.000948267],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009264025,"threshold_uncertainty_score":0.003099144,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02877557707826679,"score_gpt":0.3057353426982065,"score_spread":0.2769597656199397,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}